KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding KALA BIO, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 32 | 2 | 30 | 0 |
| Shares | 2.84M | 91.0K | 1.70M | −1.05M (−38.1%) |
| Value | $1.58M | $50.6K | $294.0K | −$1.24M (−80.8%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held KALA BIO, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 84,470 | $15.0K | 0.00% |
| Vanguard Capital Management LLC | 60,549 | $10.5K | 0.00% |
| Vanguard Fiduciary Trust Co | 29,628 | $5.13K | 0.00% |
| Grant Private Wealth Management Inc | 20,000 | $3.46K | 0.00% |
| Greenwich Wealth Management LLC | 18,393 | $3.00K | 0.00% |
| LPL Financial LLC | 17,229 | $2.98K | 0.00% |
| Goldman Sachs Group Inc | 14,048 | $2.43K | 0.00% |
| Vanguard Global Advisers, LLC | 832 | $144 | 0.00% |
| Harbour Investments, Inc. | 150 | $26 | 0.00% |
Sold out (9)
Institutions that held KALA BIO, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Baker Bros. Advisors LP | 1,804,055 | $1.00M |
| Woodline Partners LP | 224,174 | $124.6K |
| XTX Topco Ltd | 28,278 | $15.7K |
| Two Sigma Investments, LP | 26,900 | $15.0K |
| Two Sigma Securities, LLC | 13,105 | $7.29K |
| Citigroup Inc | 11,596 | $6.45K |
| SG Americas Securities, LLC | 10,359 | $6.00K |
| Fortitude Family Office, LLC | 709 | $394 |
| Bank of America Corp | 296 | $165 |
Not filed for Q1 2026 yet (2)
Institutions that held KALA BIO, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 91,009 | $50.6K |
| Motiv8 Investments LLC | 2 | $0 |